We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

1 hedge funds and large institutions have $2.03K invested in Genetic Technologies Ltd. in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $2.03K → $2.03K ($0)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$2.03K – – –

GENE Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2026, worth a combined $2.03K — unchanged from a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of GENE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held Genetic Technologies Ltd. (GENE) as of Q1 2026, down from 2 in Q4 2025.
  • Funds reported $2.03K of Genetic Technologies Ltd. stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Genetic Technologies Ltd. positions in Q1 2026 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q1 2026.